References
- Maldonado YA, Read JS. Committee on Infectious Diseases. Diagnosis, Treatment, and Prevention of Congenital Toxoplasmosis in the United States. Pediatrics. 2017;139(2):e20163860; DOI:10.1542/peds.2016-3860.
- European Centre for Disease Prevention and Control. Congenital toxoplasmosis. In: ECDC. Annual epidemiological report for 2016. Stockholm:ECDC. 2019.
- Ozgonul C, Besirli CG. Recent Developments in the Diagnosis and Treatment of Ocular Toxoplasmosis. Ophthalmic Res. 2017;57(1):1–12; DOI:10.1159/000449169.
- McLeod R, Boyer K. Toxoplasmosis (Toxoplasma gondii). In: Kliegman RA, St Geme JW, Blum NJ, Shah SS, Tasker RC, Wilson KM , Behrman RE, editors. Nelson Textbook of Pediatrics. 21th ed. Philadelphia: Elsevier Health Sciences. 2019;316:1865-1877.
- Park Y-H, Nam H-W. Clinical Features and Treatment of Ocular Toxoplasmosis. Korean J Parasitol. 2013;51(4):393–9; DOI:10.3347/kjp.2013.51.4.393.
- Muñoz-Roldan M, Heimesaat MM, Liesenfeld O. Toxoplasmosis. In: Manson’s Tropical Infectious Diseases. Elsevier. 2014;652-663; DOI:10.1016/B978-0-7020-5101-2.00049-2.
- Giugno S, Monteleone MM, Insalaco G, Leanza G, Palumbo M, Leanza V. Congenital toxoplasmotic chorioretinitis following reinfection. Eur J Obstet Gynecol Reprod Biol. 2020; 251:263-265; DOI:10.1016/j. ejogrb.2020.04.045.
- Sáfadi MAP, Berezin EN, Farhat CK, Carvalho ES. Clinical presentation and follow up of children with congenital toxoplasmosis in Brazil. Braz J Infect Dis. 2003;7(5); DOI:10.1590/S1413-86702003000500007.
- Feliciano-Alfonso JE, Vargas-Villanueva A, Marin MA, Trivino L, Carvajal N, Moreno M, Luna T, Lopez de Mesa C, Muñoz-Ortiz J, de-la-Torre A. Antibiotic treatment for ocular toxoplasmosis: a systematic review and meta-analysis: study protocol. Syst Reviews 8. 2019;146; DOI:10.1186/s13643-019-1067-8.
- Kaye A. Toxoplasmosis: Diagnosis, Treatment, and Prevention in Congenitally Exposed Infants. J Pediatr Health Care. 2011;25(6):355–64; DOI:10.1016/j.pedhc.2010.04.008.
- Jones JL, Ogunmodede F, Scheftel J, Kirkland E, Lopez A, Schulkin J, Lynfield R. Toxoplasmosis-Related Knowledge and Practices Among Pregnant Women in the United States. Infect Dis Obstet Gynecol. 2003;11(3):139–45; DOI:10.1080/10647440300025512.
- Oray M, Ozdal PC, Cebeci Z, Kir N, Tugal-Tutkun I. Fulminant Ocular Toxoplasmosis: The Hazards of Corticosteroid Monotherapy. Ocul Immunol Inflamm. 2016;24(6):637-646; DOI:10.3109/09273948.2015.1 057599.
- Soheilian M, Ramezani A, Azimzadeh A, Sadoughi MM, Dehghan MH, Shahghadami R, Yaseri M, Peymanet GA. Randomized Trial of Intravitreal Clindamycin and Dexamethasone versus Pyrimethamine, Sulfadiazine, and Prednisolone in Treatment of Ocular Toxoplasmosis. Ophthalmology. 2011;118(1):134–41; DOI:10.1016/j.ophtha.2010.04.020.
- Prednisone: Drug information [Internet]. UpToDate: Lexicomp; Copyright 1978-2021. Prednisone [cited 10 May 2021]. Available from: https://www.uptodate.com/contents/prednisone-drug-information?topicRef=850&source=see_link